The Enterprise Value as of June 2026 (TTM) for Atea Pharmaceuticals, Inc. (AVIR) is 280.64M

According to Atea Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 280.64M. This represents a change of 24.81% compared to the average of 224.85M of the last 4 quarters.

Atea Pharmaceuticals, Inc. (AVIR) Historical Enterprise Value (quarterly & annually)

How has AVIR Enterprise Value performed in the past?

The mean historical Enterprise Value of Atea Pharmaceuticals, Inc. over the last ten years is 701.50M. The current 280.64M Enterprise Value has changed 3.90% with respect to the historical average. Over the past ten years (40 quarters), AVIR's Enterprise Value was at its highest in in the March 2021 quarter at 4.27B. The Enterprise Value was at its lowest in in the December 2022 quarter at -242971456.41.

Atea Pharmaceuticals, Inc. (AVIR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atea Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atea Pharmaceuticals, Inc. (AVIR) Average Enterprise Value

How has AVIR Enterprise Value performed in the past?

The current Enterprise Value of Atea Pharmaceuticals, Inc. (AVIR) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Atea Pharmaceuticals, Inc. (AVIR) Enterprise Value vs. Peers

How is AVIR’s Enterprise Value compared to its peers?

Atea Pharmaceuticals, Inc.’s Enterprise Value is greater than Voyager Therapeutics, Inc. (202.73M), less than Vanda Pharmaceuticals Inc. (312.03M), less than Allogene Therapeutics, Inc. (514.09M), greater than Entrada Therapeutics, Inc. (224.09M), greater than Pyxis Oncology, Inc. (122.52M), greater than Humacyte, Inc. (194.60M), less than Enanta Pharmaceuticals, Inc. (427.97M), less than Achieve Life Sciences, Inc. (553.55M), greater than Arcturus Therapeutics Holdings Inc. (6.41M),

Build a custom stock screener for Atea Pharmaceuticals, Inc. (AVIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atea Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atea Pharmaceuticals, Inc. (AVIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atea Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.